The National Institute for Innovation in Manufacturing Biopharmaceuticals ( NIIMBL ) is pleased to announce 11 new member-led technology, workforce development, and Global Health Fund projects with a value of ~$11.2 million through the Institute’s Project Call 8.1. This new slate of collaborative projects addresses key industry challenges and aims...

Today, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced 32 coronavirus response projects to multiple organizations across the United States funded through the American Rescue Plan (ARP).

NIIMBL identified projects that will help the nation prevent, prepare for, and respond to coronavirus public health...

The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has made two awards totaling $153 million to the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). The awards were announced today by U.S. Secretary of Commerce Gina Raimondo at the NIIMBL annual meeting in Washington, D.C.

NIIMBL...

NEWARK, Del. & ALEXANDRIA, Va., April 18, 2019 - The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) in partnership with the Healthcare Innovation Special Interest Group (HISIG) of the National Society of Black Engineers (NSBE) are pleased to announce the selection of seven students for the inaugural NIIMBL eXperience...

Expanding efforts focused on strengthening US-based manufacturing, the Department of Defense announced the award of a new public-private Manufacturing USA institute to Advanced Regenerative Manufacturing Institute (ARMI) today. This new institute will be the 12th Manufacturing USA institute established, with the Department of Defense now leading...